Skip to main content
Premium Trial:

Request an Annual Quote

ITI Life Sciences Funds Synthetic Bio Project

NEW YORK (GenomeWeb News) – Scottish organization ITI Life Sciences said today that it has invested £2.5 ($4.1 million) to commission a research collaboration involving Heriot-Watt University in Edinburgh and the synthetic biology company Ginkgo BioWorks in a genome segment assembly program.

The aim of the collaboration is to develop a prototype technology that could be used to efficiently assemble small DNA segments into larger and more complex fragments, such as biosynthetic pathways. The 18-month project seeks to develop an automated and reliable system for high-throughput assembly of DNA segments.

"There is a clear market need for new technologies enabling an automated process for large scale DNA assembly," ITI Life Sciences Managing Director Eleanor Mitchell said in a statement. "This program provides a tremendous opportunity for Scotland to gain competitive advantage and capitalize on a relatively immature and innovative market."

"We believe the use of integrated microfluidic systems will provide the biologists with a powerful platform for advancing synthetic biology, and that the combined strength of the highly interdisciplinary teams put together by this ITI program is well placed to achieve this," Heriot-Watt University microengineeering Professor Will Shu added.

ITI Life Sciences is a division of ITI Scotland, a publicly funded organization focused on economic growth through R&D programs in energy, digital media and communications, and the life sciences.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.